FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implantable Pacemaker Pulse-Generator

PMA: P910023 · Supplement: S071 · Decision Nov 6, 2003
Classifications
1
FEI Numbers
28
Registration Numbers
28

Basic Information

Device Name
Implantable Pacemaker Pulse-Generator
Trade Name
HOUSECALL PLUS TRANSTELEPHONIC MONITORING SYSTEM WITH MODEL 3180-T TRANSMITTER (SOFTWARE VERSION 1.1) AND MODEL 3180-R
PMA Number
P910023
Supplement Number
S071
Device Class
FDA Class 3
Product Code
DXY
Generic Name
implantable pacemaker Pulse-generator
Regulation Number
870.3610
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
November 6, 2003
Date Received
October 7, 2003
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR MODIFICATIONS TO THE HOUSECALL 2.0 SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME HOUSECALL PLUS TRANSTELEPHONIC MONITORING SYSTEM AND IS INDICATED AS FOLLOWS: THE HOUSECALL PLUS SYSTEM IS INDICATED FOR USE IN PERFORMING REMOTE FOLLOW-UP MONITORING ON PATIENTS HAVING THE FOLLOWING ST. JUDE MEDICAL CARDIOVERTER/ DEFRIBRILLATORS: ATLAS DR MODEL V-240, ATLAS VR MODEL V-199, EPIC+ DR MODEL V-236, EPIC+ VR MODEL V-1961, EPIC DR MODEL V-235 AND EPIC VR MODEL V-197.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DXY Implantable Pacemaker Pulse-Generator